los angeles  reuters    california voters turned down a ballot initiative aimed at reining in rising prices for prescription drugs after pharmaceutical companies spent more than   million to fight it  the california drug price relief act  also known as proposition   sought to limit state health programs from paying more for medications than the u s  department of veterans affairs  va   which receives the steepest discounts in the country   as of wednesday morning  with more than  percent of precincts partially reporting from tuesday s election  the vote was  percent in favor of the measure and  percent opposed  according to california s secretary of state   the pharmaceutical companies spent a lot to defeat this   said stuart schweitzer  professor of health policy and management at the university of california  los angeles fielding school of public health   they wanted to draw a line in the sand   the measure s defeat  reaffirms the power of the biopharma lobby   jefferies analyst brian abrahams said in a note to investors on wednesday  the rising cost of prescription drugs came under attack during the u s  presidential campaign  both president elect donald trump and democratic candidate hillary clinton called for cost trimming measures including allowing medicare  the federal health plan for seniors  to negotiate prices with drugmakers  shares in pharmaceutical and biotechnology shares  under pressure in recent weeks  soared on wednesday as market fears of a win by clinton and democrats gaining power in congress receded  the nasdaq biotechnology index  nbi advanced  percent and was on track for its biggest single day gain in about five years      proposition  s opponents  led by global drugmakers such as pfizer inc and amgen inc  spent around   million  they argued that it would benefit only  percent of californians  while putting the other  percent  and veterans across the country  at risk of higher drug costs  supporters  led by the aids healthcare foundation and aarp  which advocates for seniors  said only drug companies themselves can raise prices for veterans or other consumers  vermont independent senator bernie sanders also campaigned in support of proposition   calling on voters to  stand up to the greed of the pharmaceutical industry   proponents  who raised   million to support the initiative  estimated it could save california taxpayers up to    billion over  years  although a state legislative analysis said the financial impact is not clear  ucla s schweitzer said the measure would have had only a modest impact on state drug costs  there were also questions about how proposition  would be implemented  the va s mandated prices are listed publicly  but its steepest negotiated price discounts are required by law to be confidential  the va spends some    billion a year on medicines for  million veterans  proposition  would have extended those discounts to around   million californians  including certain members of the state s low income medicaid plan  state employees and retirees  university teachers and prisoners  a similar proposition has been approved for ohio s  november ballot   